Back to VVUS Stock Lookup

VVUS – Analyst PT Change

Apr 3, 2014 06:35 AM Piper Jaffray Downgrades Vivus (VVUS) to Underweight
Feb 25, 2014 07:57 AM JPMorgan Downgrades Vivus (VVUS) to Neutral
Jan 10, 2014 02:34 PM WallachBeth Starts Orexigen (OREX) at Buy; Sees Contrave With Edge Over Peers (ARNA) (VVUS)
Nov 25, 2013 09:43 AM Aegis Capital Boosts PT on Auxilium (AUXL) to $33; Xiaflex Bear Case Just Doesn't Play Out
Oct 16, 2013 08:42 AM UPDATE: Piper Jaffray Downgrades Vivus (VVUS) to Neutral
Oct 3, 2013 07:32 AM Cowen Upgrades Vivus (VVUS) to Outperform
Sep 12, 2013 09:16 AM Vivus (VVUS) Target Lowered to $14 from $20 at Piper
Feb 26, 2013 09:23 AM VIVUS, Inc. (VVUS) Misses Q4 Views on Heftier Qsymia Costs; Analysts Comment
Nov 7, 2012 12:33 PM Jefferies Slashes Numbers on Vivus (VVUS) on Slow Qsymia Uptake; Sees Another 45% Downside
Nov 7, 2012 11:26 AM Jefferies Remains Bullish on Arena Pharma (ARNA) But Tempers Valuation Target on Data from Rival
Nov 6, 2012 03:02 PM Needham & Company Cuts Numbers on VIVUS Inc. (VVUS) on Slower Qsymia Launch, Keeps Buy on Blockbuster Potential
Sep 24, 2012 04:39 PM Vivus (VVUS) Slammed; Analyst Sees 38% Downside
Sep 24, 2012 07:31 AM Needham & Company Cuts Target on Vivus (VVUS), Adjusts Qsymia Estimates
Jul 18, 2012 03:14 PM Wells Fargo Lifts Valuation Range on Vivus (VVUS), But Still Not Overly Bullish
Jun 28, 2012 02:54 PM JPMorgan Boosts Target on Vivus (VVUS), More Confidence in Approval
Mar 30, 2012 07:20 AM Jefferies Cuts Target on Vivus (VVUS) after FDA CV Panel, Keeps Lowest Rating
Mar 26, 2012 10:54 AM Leerink Swann Says Orexigen (OREX) is Still the Best Play After Obesity Drug CV Study Briefing Documents, Boosts Target (VVUS)
Feb 29, 2012 10:05 AM Jefferies Bumps Price Target on VIVUS (VVUS) Following Q4, Keeps Underperform Rating
Feb 23, 2012 07:44 AM Jefferies Raises Price Target on Vivus (VVUS), But Sees Risk to Qnexa Approval
Feb 23, 2012 07:42 AM JMP Securities Boosts Price Target on Vivus (VVUS) to $45

Back to VVUS Stock Lookup